JP2003501110A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003501110A5 JP2003501110A5 JP2001502873A JP2001502873A JP2003501110A5 JP 2003501110 A5 JP2003501110 A5 JP 2003501110A5 JP 2001502873 A JP2001502873 A JP 2001502873A JP 2001502873 A JP2001502873 A JP 2001502873A JP 2003501110 A5 JP2003501110 A5 JP 2003501110A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- vaccine
- seq
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 description 16
- 229920001184 polypeptide Polymers 0.000 description 13
- 108090000765 processed proteins & peptides Proteins 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 13
- 229960005486 vaccine Drugs 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 5
- 239000012634 fragment Substances 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229920000832 Cutin Polymers 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000700625 Poxviridae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13845399P | 1999-06-10 | 1999-06-10 | |
| US60/138,453 | 1999-06-10 | ||
| PCT/US2000/015925 WO2000076540A2 (en) | 1999-06-10 | 2000-06-09 | Streptococcus pneumoniae proteins and vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003501110A JP2003501110A (ja) | 2003-01-14 |
| JP2003501110A5 true JP2003501110A5 (enExample) | 2007-08-16 |
Family
ID=22482080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001502873A Pending JP2003501110A (ja) | 1999-06-10 | 2000-06-09 | 肺炎連鎖球菌タンパク質とワクチン |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1731166B1 (enExample) |
| JP (1) | JP2003501110A (enExample) |
| AT (2) | ATE500843T1 (enExample) |
| AU (1) | AU777856B2 (enExample) |
| CA (1) | CA2371714C (enExample) |
| DE (2) | DE60027890T2 (enExample) |
| ES (2) | ES2360296T3 (enExample) |
| HK (1) | HK1043943A1 (enExample) |
| WO (1) | WO2000076540A2 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7129339B1 (en) | 1997-07-02 | 2006-10-31 | Sanofi Pasteur Limited | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| US6800744B1 (en) | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| US7128918B1 (en) | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
| US7074415B2 (en) | 2000-06-20 | 2006-07-11 | Id Biomedical Corporation | Streptococcus antigens |
| GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| US7262024B2 (en) | 2001-12-20 | 2007-08-28 | Id Biomedical Corporation | Streptococcus antigens |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| JP5792920B2 (ja) | 2005-12-22 | 2015-10-14 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
| EA200901578A1 (ru) | 2007-06-26 | 2010-08-30 | Глаксосмитклайн Байолоджикалс С.А. | Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae |
| GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
| AU2008336295B2 (en) * | 2007-12-13 | 2013-07-11 | Intervacc Ab | Improved immunizing composition |
| SI2268618T1 (sl) | 2008-03-03 | 2015-09-30 | Novartis Ag | Spojine in sestavki kot modulatorji aktivnosti TLR |
| KR20110009157A (ko) | 2008-04-16 | 2011-01-27 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 |
| CA2765112A1 (en) | 2009-06-10 | 2010-12-16 | Novartis Ag | Benzonaphthyridine-containing vaccines |
| JP5931724B2 (ja) | 2009-06-29 | 2016-06-08 | ジェノセア バイオサイエンシーズ， インコーポレイテッド | ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｎｅｕｍｏｎｉａｅに対するワクチンおよび組成物 |
| US9950062B2 (en) | 2009-09-02 | 2018-04-24 | Glaxosmithkline Biologicals Sa | Compounds and compositions as TLR activity modulators |
| JO3257B1 (ar) | 2009-09-02 | 2018-09-16 | Novartis Ag | مركبات وتركيبات كمعدلات لفاعلية tlr |
| CN102695523A (zh) | 2009-09-10 | 2012-09-26 | 诺华有限公司 | 针对呼吸道疾病的组合疫苗 |
| WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
| JP5814933B2 (ja) | 2009-12-15 | 2015-11-17 | ノバルティス アーゲー | 免疫増強化合物の均質な懸濁物およびその使用 |
| GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| EA031379B1 (ru) | 2010-03-23 | 2018-12-28 | Новартис Аг | Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний |
| WO2012072769A1 (en) | 2010-12-01 | 2012-06-07 | Novartis Ag | Pneumococcal rrgb epitopes and clade combinations |
| SG10201600435UA (en) | 2011-01-20 | 2016-02-26 | Genocea Biosciences Inc | Vaccines And Compositions Against Streptococcus Pneumoniae |
| KR20140033127A (ko) | 2011-05-17 | 2014-03-17 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 스트렙토코쿠스 뉴모니애에 대한 백신 |
| WO2013131983A1 (en) | 2012-03-07 | 2013-09-12 | Novartis Ag | Adjuvanted formulations of streptococcus pneumoniae antigens |
| US9827190B2 (en) | 2013-02-01 | 2017-11-28 | Glaxosmithkline Biologicals Sa | Intradermal delivery of immunological compositions comprising toll-like receptor 7 agonists |
| GB201711635D0 (en) | 2017-07-19 | 2017-08-30 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| BR112020016314A2 (pt) | 2018-02-12 | 2020-12-15 | Inimmune Corporation | Compostos ou um sais farmaceuticamente aceitáveis, composição farmacêutica, kit, e, métodos para elicitar, intensificar ou modificar uma resposta imunológica, para tratar, prevenir ou reduzir a suscetibilidade a câncer, para tratar, prevenir ou reduzir a suscetibilidade a uma doença infecciosa, para tratar, prevenir ou reduzir a suscetibilidade a uma alergia, para tratar, prevenir ou reduzir a suscetibilidade a uma afecção autoimune, para tratar, prevenir ou reduzir a suscetibilidade em um sujeito à infecção bacteriana, viral, priônica, autoimunidade, câncer ou alergia, para tratar, prevenir ou reduzir a suscetibilidade à autoimunidade, alergia, reperfusão de isquemia ou sepse, para tratar, prevenir ou reduzir a gravidade de ataques epiléticos e para tratar, prevenir ou reduzir a suscetibilidade a doenças oculares como degeneração macular, hipertensão ocular e infecção ocular |
| KR20230117105A (ko) | 2020-11-04 | 2023-08-07 | 엘리고 바이오사이언스 | 큐티박테리움 아크네스 재조합 파지, 그의 제조 방법 및 용도 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE348887T1 (de) * | 1996-10-31 | 2007-01-15 | Human Genome Sciences Inc | Streptococcus pneumoniae antigene und impfstoffe |
| EP1144640A3 (en) * | 1998-07-27 | 2001-11-28 | Microbial Technics Limited | Nucleic acids and proteins from streptococcus pneumoniae |
-
2000
- 2000-06-09 AU AU54778/00A patent/AU777856B2/en not_active Ceased
- 2000-06-09 HK HK02105081.7A patent/HK1043943A1/zh unknown
- 2000-06-09 AT AT06009322T patent/ATE500843T1/de not_active IP Right Cessation
- 2000-06-09 EP EP06009322A patent/EP1731166B1/en not_active Expired - Lifetime
- 2000-06-09 AT AT00939739T patent/ATE325620T1/de not_active IP Right Cessation
- 2000-06-09 DE DE60027890T patent/DE60027890T2/de not_active Expired - Lifetime
- 2000-06-09 DE DE60045721T patent/DE60045721D1/de not_active Expired - Lifetime
- 2000-06-09 EP EP00939739A patent/EP1185297B1/en not_active Expired - Lifetime
- 2000-06-09 ES ES06009322T patent/ES2360296T3/es not_active Expired - Lifetime
- 2000-06-09 CA CA2371714A patent/CA2371714C/en not_active Expired - Fee Related
- 2000-06-09 JP JP2001502873A patent/JP2003501110A/ja active Pending
- 2000-06-09 ES ES00939739T patent/ES2264419T3/es not_active Expired - Lifetime
- 2000-06-09 WO PCT/US2000/015925 patent/WO2000076540A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2371714A1 (en) | Streptococcus pneumoniae proteins and vaccines | |
| JP2003515323A5 (enExample) | ||
| JP2006525330A5 (enExample) | ||
| RU2006127314A (ru) | Вакцина, стимулирующая рост, основанная на нейтрализующем эпитопе | |
| CN1610697A (zh) | 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途 | |
| EP2292644A3 (en) | Small Streptococcus pyogenes antigens and their use | |
| CA2674837A1 (en) | Anti-ige vaccines | |
| CA2144307A1 (en) | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides | |
| JP2003530872A5 (enExample) | ||
| NO20011381L (no) | Preparater av streptokokk C<beta>-protein | |
| IL127595A0 (en) | Polypeptides capable of forming antigen binding structures with specificity for the rhesus D antigens the DNA encoding them and the process for their preparation and use | |
| JP2002534481A5 (enExample) | ||
| CA2249746A1 (en) | Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis | |
| DK200601181A (da) | Fiskevaccine | |
| CA2967778A1 (en) | Anti-thyroglobulin t cell receptors | |
| IL125645A0 (en) | Recombinant phages | |
| CA2411919A1 (en) | Immunization of dairy cattle with chimeric gapc protein against streptococcus infection | |
| CA2475821A1 (en) | Group b streptococcus antigens | |
| CA2338886A1 (en) | Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response | |
| CA2353802A1 (en) | New protective antigen of group a streptococci | |
| JP2005535287A5 (enExample) | ||
| KR20010081018A (ko) | 항원 유전자 서열의 동정 방법 | |
| JP2004502782A5 (enExample) | ||
| CA2411927A1 (en) | Immunization of dairy cattle with gapc protein against streptococcus infection | |
| JP2004531235A5 (enExample) |